Frank Kenneth Schweighardt

This inventor holds 27 USPTO granted patents, plus 7 CIPO patents and 1 EPO patent, primarily in Gas Delivery Systems. Top assignees: Air Products and Chemicals, Inc., Mallinckrodt Hospital Products IP Limited, Mallinckrodt Pharmaceuticals Ireland Limited. Active years: 1984-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank Kenneth Schweighardt. Retrieved from https://idiyas.com/inventor/frank-kenneth-schweighardt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27

% Patents Active = 81.5

CIPO Patents = 7 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.7

ph-index = 11

Forward Citations = 515(Granted Patents)

Company Filing History:

24 out of 3,219

Air Products and Chemicals, Inc.

patents

1 out of 83

Mallinckrodt Hospital Products IP Limited

patents

1 out of 63

Mallinckrodt Pharmaceuticals Ireland Limited

patents

4. 1 out of 834,570

Other

patents

Years Active: 1984-2022

Loading Chart...

Areas of Expertise:

Inhalation Therapy

Gas Purity Monitoring

Liquid Particle Measurement

Fueling Nozzle

Fluorochemical Emulsions

Perfluoro-Crown Ethers

Catalytic Hydroconversion

Coal Liquefaction

Molecular Leak Sensor

Gas Transport

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11324912 - Systems and methods for indicating lifetime of an NO-to-NO reactor cartridge used to deliver NO for inhalation therapy to a patient (2022-05-10),

2. 10525226 - Systems and methods for indicating lifetime of an NO2-to-NO reactor cartridge used to deliver NO for inhalation therapy to a patient (2020-01-07),

3. 7793675 - In-line gas purity monitoring and control system (2010-09-14),

4. 7481095 - Liquid particle mass measurement in gas streams (2009-01-27),

5. 7438079 - In-line gas purity monitoring and control system (2008-10-21),

6. 7343781 - Systems and methods for detecting liquid particles in a gas system (2008-03-18),

7. 7191805 - Fueling nozzle with integral molecular leak sensor (2007-03-20),

8. 7028724 - Fueling nozzle with integral molecular leak sensor (2006-04-18),

9. 5789505 - Surfactants for use in liquid/supercritical CO.sub.2 (1998-08-04),

10. 5196348 - Perfluoro-crown ethers in fluorine magnetic resonance spectroscopy of (1993-03-23),

11. 5068098 - Perfluoro-crown ethers in fluorine magnetic resonance spectroscopy (1991-11-26),

12. 4956390 - Gas transport employing perfluorobutyldecalin (1990-09-11),

13. 4925992 - Perfluorinated 2-ISO propyl derivative compounds (1990-05-15),

14. 4901910 - Perfluorinated propyl derivative compounds for vapor bath soldering (1990-02-20),

15. 4895876 - Concentrated stable fluorochemical aqueous emulsions containing (1990-01-23),

Title: The Innovative Mind of Frank Kenneth Schweighardt

Introduction

Frank Kenneth Schweighardt, a prolific inventor hailing from Allentown, PA, has made significant contributions in the field of medical technology. With an impressive portfolio of 27 patents, his work has focused on enhancing safety and efficacy in delivering nitric oxide (NO) for inhalation therapy.

Latest Patents

One of Schweighardt's latest patents includes "Systems and methods for indicating lifetime of an NO-to-NO reactor cartridge used to deliver NO for inhalation therapy to a patient." These systems and methods aim to address safety concerns associated with the exhaustion of consumable reactants in NO2-to-NO reactor cartridges by providing indicators of remaining useful life and potential breakthrough of NO.

Career Highlights

Having worked at renowned companies like Air Products and Chemicals, Inc., Schweighardt has honed his skills and expertise in the field of chemical engineering and medical device innovation. His dedication to improving healthcare technologies has been evident throughout his career.

Collaborations

Schweighardt has collaborated with esteemed professionals in his field, including Webb I Bailey and Joseph Perry Cohen. These collaborations have led to the development of groundbreaking solutions in the delivery of NO for inhalation therapy, further cementing Schweighardt's reputation as a pioneering inventor.

Conclusion

Frank Kenneth Schweighardt's inventive spirit and commitment to advancing medical technologies have left a lasting impact on the field of inhalation therapy. His innovative solutions continue to pave the way for safer and more effective treatment options, ensuring better outcomes for patients in need.

Profile summary based on public USPTO records.